FDA inspection
Thomas E. Hutson, D0.: FDA inspection ending Feb 16, 2016
FDA inspection 960317 · Voluntary Action Indicated (VAI) · Dallas, TX
Key facts
| Inspection ID | 960317 |
|---|---|
| Firm | Thomas E. Hutson, D0. |
| FEI number | 3005904911 |
| Address | Texas Oncology, Sammons Cancer Center, 3410 Worth St. Suite 400 |
| City | Dallas |
| State | TX |
| ZIP | 75246 |
| Country | United States |
| Fiscal year | 2016 |
| Inspection end date | Feb 16, 2016 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data